FULC — FULCRUM THERAPEUTICS INC

Ownership history in BRAIDWELL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in FULCRUM THERAPEUTICS INC (FULC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.11% (2025 Q4)
Avg. % of fund
0.43%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 3,061,222 +2,841,734 +1294.7% 1.11% $34.6M $11.31
2025 Q3 REDUCED 219,488 -849,670 -79.5% 0.06% $2.0M $9.20
2024 Q3 INITIATED 1,069,158 — — 0.11% $3.8M $3.57
% of Fund (quarterly)    FULC price (monthly, adj. close)

Other funds also holding FULC

As of 2025 Q4 — sorted by position size

GREAT POINT PARTNERS LLC 3Y 7Y 2.93% GSK plc 2.53% First Turn Management, LLC 2.45% TCG Crossover Management, LLC 3Y 1.97% Nantahala Capital Management, LLC 3Y 7Y 1.61% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.52% Ikarian Capital, LLC 3Y 1.21% ADAR1 Capital Management, LLC 1.03% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.7% Sio Capital Management, LLC 3Y 7Y 0.68%
← Back to BRAIDWELL LP Holdings